Browsing articles from "May, 2022"

ROP Safety Net Revision

May 9, 2022

Dear Colleague:

The International Classification of Retinopathy of Prematurity, Third Edition1 (ICROP3) was released last year. We revised the clinical tables and recommendations in our ROP Safety Net accordingly.

ICROP3 changes updated in the OMIC Safety Net:

·       The definition of aggressive ROP replaces aggressive-posterior ROP

·       A continuous spectrum of vascular abnormality exists from normal to plus disease

·       Regression and reactivation should be documented

Updated/new consent forms:

·       Update to informed consent to inject

·       Update to informed consent for laser

·       NEW: Telemedicine services consent

Minor changes to the following letters:

·       Discharge from hospital

·       Transfer to treat

·       Transfer for other care

·       Missed appointment

·       Outpatient screening

We are working on Spanish translation of the updated consent forms and letters. You should update your consent forms and letters immediately (even though Spanish translation is not available).

You may access the revised clinical tables and the entire ROP Safety Net at http://www.omic.com/rop-safety-net/. Remember that you may contact the Risk Management Hotline for confidential assistance at riskmanagement@omic.com or 800-562-6642, option 4.

Sincerely,

Robert S. Gold, MD
Chair of the OMIC ROP Task Force

________________________________________

Chang MF, Quinn GE, Fielder AR, Wu WC, Zhao P, Zin A, et al. International Classification of Retinopathy of Prematurity, Third Edition. Ophthalmology. 2021;128(10):E51-E68. Available at: https://doi.org/10.1016/j.ophtha.2021.05.031 (Accessed: 3/10/22)

CONFIDENTIALITY NOTICE: This correspondence is intended only for the person or entity to which it is addressed and may contain information that is privileged, confidential or otherwise protected from disclosure. Dissemination, distribution or copying of this e-mail or the information herein by anyone other than the intended recipient, or an employee or agent responsible for delivering the message to the intended recipient, is prohibited. If you have received this e-mail in error, please call me and destroy the original message and all copies.
_________________________________________________

 

 




Six reasons OMIC is the best choice for ophthalmologists in America.

Leader in the industry.

A-rated by AM Best, OMIC is consistently ranked among the top malpractice insurance companies in America for financial stability. No other carrier has matched OMIC's consistent financial performance with regard to both combined, operating, and surplus ratios, the most relevant financial measurements for an insurance carrier.

61864684